These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17605216)

  • 1. [Evaluation of blood tests, complement-mediated lysis and polymerase chain reaction in the verification of therapeutic efficacy in Chagas disease].
    Meira WS; de Castro AM; Gontijo ED; Rassi A; Luquetti AO; Machado-Coelhos GL; Chiari E; Galvão LM
    Rev Soc Bras Med Trop; 2006; 39 Suppl 3():107-9. PubMed ID: 17605216
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trypanosoma cruzi high parasitemia in patient with systemic lupus erythematosus].
    dos Santos-Neto LL; Polcheira MF; Castro C; Lima RA; Simaan CK; Corrêa-Lima FA
    Rev Soc Bras Med Trop; 2003; 36(5):613-5. PubMed ID: 14576877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New advances in the management of a long-neglected disease.
    Urbina JA
    Clin Infect Dis; 2009 Dec; 49(11):1685-7. PubMed ID: 19877968
    [No Abstract]   [Full Text] [Related]  

  • 4. Chagas disease and liver transplantation: Experience in Argentina using real-time quantitative PCR for early detection and treatment.
    Balderramo D; Bonisconti F; Alcaraz A; Giordano E; Sánchez A; Barrabino M; Caeiro JP; Alvarellos T; Maraschio M
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28941300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi: sensitivity of the polymerase chain reaction for detecting the parasite in the blood of mice infected with different clonal genotypes.
    Miyamoto CT; Gomes ML; Marangon AV; Araújo SM; Bahia MT; Lana M; Toledo MJ
    Exp Parasitol; 2006 Mar; 112(3):198-201. PubMed ID: 16376332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole.
    Miyamoto CT; Gomes ML; Marangon AV; de Araújo SM; Bahia MT; Martins-Filho OA; de Lana M; de Ornelas Toledo MJ
    Exp Parasitol; 2008 Sep; 120(1):45-9. PubMed ID: 18533149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological profiles and evaluation of parasitaemia by PCR and blood culture in individuals chronically infected by Trypanosoma cruzi treated with benzonidazole.
    Aguiar C; Batista AM; Pavan TB; Almeida EA; Guariento ME; Wanderley JS; Costa SC
    Trop Med Int Health; 2012 Mar; 17(3):368-73. PubMed ID: 22212647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood culture and polymerase chain reaction for the diagnosis of the chronic phase of human infection with Trypanosoma cruzi.
    Castro AM; Luquetti AO; Rassi A; Rassi GG; Chiari E; Galvão LM
    Parasitol Res; 2002 Oct; 88(10):894-900. PubMed ID: 12209329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and Chagas Disease: An Evaluation of the Use of Real-Time Quantitative Polymerase Chain Reaction to Measure Levels of Trypanosoma cruzi Parasitemia in HIV Patients in Cochabamba, Bolivia.
    Reimer-McAtee MJ; Mejia C; Clark T; Terle J; Pajuelo MJ; Cabeza J; Lora MH; Valencia E; Castro R; Lozano D; Bern C; Torrico F; Gilman RH
    Am J Trop Med Hyg; 2021 Aug; 105(3):643-650. PubMed ID: 34398818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymerase chain reaction (PCR) as a laboratory tool for the evaluation of the parasitological cure in Chagas disease after specific treatment.
    Britto C; Cardoso A; Silveira C; Macedo V; Fernandes O
    Medicina (B Aires); 1999; 59 Suppl 2():176-8. PubMed ID: 10668261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic performance of recombinant Trypanosoma cruzi ribosomal P2beta protein is influenced by its expression system.
    Marcipar IS; Olivares ML; Robles L; Dekanty A; Marcipar A; Silber AM
    Protein Expr Purif; 2004 Mar; 34(1):1-7. PubMed ID: 14766295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of measure of parasitemia in patients infected with Trypanosoma cruzi in Atacama, Chile].
    Carrasco M; Andrade W; Jercic MI; Fernández J; Miranda C; Rivera J; González J; González L; Ramírez E
    Rev Med Chil; 2003 Aug; 131(8):881-6. PubMed ID: 14558242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of a PCR test based on the histone H2A/SIRE genes with classical serological tests for the diagnosis of chronic Chagas disease in Colombian patients].
    Gil J; Pavía P; Montilla M; Florez AC; Quintero C; Mercado M; Vacca M; Nicholls S; Puerta C
    Biomedica; 2007 Jan; 27 Suppl 1():83-91. PubMed ID: 18154248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis and treatment monitoring of congenital transmission of Trypanosoma cruzi to twins of a triplet delivery.
    Burgos JM; Altcheh J; Petrucelli N; Bisio M; Levin MJ; Freilij H; Schijman AG
    Diagn Microbiol Infect Dis; 2009 Sep; 65(1):58-61. PubMed ID: 19679236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCg).
    Güida MC; Esteva MI; Camino A; Flawiá MM; Torres HN; Paveto C
    Exp Parasitol; 2007 Oct; 117(2):188-94. PubMed ID: 17673202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone and itraconazole: a rational therapeutic approach for the treatment of chronic Chagas' disease.
    Paniz-Mondolfi AE; Pérez-Alvarez AM; Lanza G; Márquez E; Concepción JL
    Chemotherapy; 2009; 55(4):228-33. PubMed ID: 19451712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies?
    Gomes YM; Lorena VM; Luquetti AO
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():115-21. PubMed ID: 19753466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes.
    Martins HR; Figueiredo LM; Valamiel-Silva JC; Carneiro CM; Machado-Coelho GL; Vitelli-Avelar DM; Bahia MT; Martins-Filho OA; Macedo AM; Lana M
    J Antimicrob Chemother; 2008 Jun; 61(6):1319-27. PubMed ID: 18343804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice.
    Francisco AF; de Abreu Vieira PM; Arantes JM; Pedrosa ML; Martins HR; Silva M; Veloso VM; de Lana M; Bahia MT; Tafuri WL; Carneiro CM
    Exp Parasitol; 2008 Dec; 120(4):314-9. PubMed ID: 18789321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of complement mediated lysis technic in patients with chronic Chagas' disease treated with trypanocidal drugs].
    Levy AM; Pereira VL; Boainain E
    Rev Inst Med Trop Sao Paulo; 1988; 30(1):32-9. PubMed ID: 3146793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.